Evidence map›Paper›PMID 38001639›Full record

ArticleCancers2023

Association between the Preoperative Standard Uptake Value (SUV) and Survival Outcomes after Robotic-Assisted Segmentectomy for Resectable Non-Small Cell Lung Cancer (NSCLC).

Aihab Aboukheir Aboukheir, Emilio Q Villanueva, Joseph R Garrett, Carla C Moodie, Jenna R Tew, Eric M Toloza, Jacques P Fontaine, Jobelle J A R Baldonado

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 0 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Aihab Aboukheir AboukheirDepartment of General Surgery, Saint Luke Episcopal Medical Center, General Surgery Residency, Ponce Health Sciences University, Ponce, PR 00716, USA.ORCID 0000-0001-5491-1035
Emilio Q VillanuevaDepartment of Pathology, University of the Philippines College of Medicine, Manila City 1000, Philippines.ORCID 0000-0001-8543-9239
Joseph R GarrettDepartment of Thoracic Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA.
Carla C MoodieDepartment of Thoracic Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA.
Jenna R TewDepartment of Thoracic Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA.
Eric M TolozaDepartment of Thoracic Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA.
Jacques P FontaineDepartment of Thoracic Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA.
Jobelle J A R BaldonadoDepartment of Thoracic Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA.ORCID 0000-0002-3120-4319
Moffitt Cancer Center · USPhilippine General Hospital · PHPonce Health Sciences University · PR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLung-sparing procedures, specifically segmentectomies and wedge resections, have increased over the years to treat early-stage non-small cell lung cancer (NSCLC). We investigate here the perioperative and long-term outcomes of patients who underwent robotic-assisted segmentectomy (RAS) at an NCI-designated cancer center and aim to show associations between the preoperative standard update value (SUV) to tumor stage, recurrence patterns, and overall survival.

methodsA retrospective analysis was performed on 166 consecutive patients who underwent RAS at a single institution from 2010 to 2021. Of this number, 121 robotic-assisted segmentectomies were performed for primary NSCLC, and a total of 101 patients were evaluated with a PET-CT scan. The SUV from the primary tumor was determined from the PET-CT. The clinical, surgical, and pathologic profiles and perioperative outcomes were summarized via descriptive statistics. Numerical variables were described as the median and interquartile range because all numerical variables were not normally distributed as assessed by the Shapiro-Wilk test of normality. Categorical variables were described as the count and proportion. Chi-square or Fisher's exact test was used for association. The main outcomes were overall survival (OS) and recurrence-free survival (RFS). Kaplan-Meier (KM) curves were constructed to visualize the OS and RFS, which were also stratified according to tumor histology, the pathologic stage, and standard uptake value. A log-rank test for the equality of survival curves was performed to determine significant differences between groups.

resultsThe most common postoperative complications were atrial fibrillation (8.8%, 9/102), persistent air leak (7.84%, 8/102), and pneumonia (4.9%, 5/102). The median operative duration was 168.5 min (IQR 59), while the median estimated blood loss was 50 mL (IQR 125). The conversion rate to thoracotomy in this cohort was 3.9% (4/102). Intraoperative complications occurred in 2.9% (3/102). The median hospital length of stay was 3 days (IQR 3). The median chest tube duration was 3 days (IQR 2), but 4.9% (5/102) of patients were sent home with a chest tube. The recurrence for this cohort was 28.4% (29/102). The time to recurrence was 353 days (IQR 504), while the time to mortality was 505 days (IQR 761). The NSCLC patients were divided into the following two groups: low SUV (<5,

conclusionRobotic-assisted segmentectomy for NSCLC has reasonable perioperative and oncologic outcomes. Furthermore, we demonstrate here the prognostic implication of preoperative SUV to pathologic outcomes, recurrence-free survival, and overall survival.

Indexed as

lobectomynon-small cell lung cancer (NSCLC)overall survival (OS)recurrence-free survival (RFS)segmentectomystandard update value (SUV)

Identifiers

PMID38001639
PMCPMC10670906
OpenAlexW4388633466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.